Nanocarrier Based Anticancer Drug Delivery System: Current Trends and Prospects

The word"personalized medicine" wasregularlylabelled as providing patient withtheright drug at the right dose
at the right time.Personalized medicine was being advanced through data from the Human Genome Project.
Cancer was a disease of the genome. In cancer, different tumours may have the same DNA, but the gene
expression pattern was different in different tumour types.Genomic variations in EGFR and ERCC1 have been
correlated with drug response in small cell lung cancer patients, HER2, BRCA1 in breast cancer.The isolation
and analysis of CTCs may be a useful method for tracking how cancers evolve during therapy.Personalized
medicine was receiving a large amount of growing attention for its tremendous potential with new opportunities.